These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25478775)

  • 1. Liver metastases from neuroendocrine tumors.
    Kennedy A
    Future Oncol; 2014 Nov; 10(15 Suppl):83-7. PubMed ID: 25478775
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic strategies for neuroendocrine liver metastases.
    Frilling A; Clift AK
    Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.
    Pavel M; Baudin E; Couvelard A; Krenning E; Öberg K; Steinmüller T; Anlauf M; Wiedenmann B; Salazar R;
    Neuroendocrinology; 2012; 95(2):157-76. PubMed ID: 22262022
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK; Saif MW
    JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and complications of treating neuroendocrine metastases, embolization versus chemoembolization.
    Hartnell GG
    J Vasc Interv Radiol; 1999; 10(10):1416-7. PubMed ID: 10584661
    [No Abstract]   [Full Text] [Related]  

  • 6. Multimodality treatment of neuroendocrine liver metastases.
    Karabulut K; Akyildiz HY; Lance C; Aucejo F; McLennan G; Agcaoglu O; Siperstein A; Berber E
    Surgery; 2011 Aug; 150(2):316-25. PubMed ID: 21801968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver-Directed Therapies for Neuroendocrine Neoplasms.
    Clift AK; Frilling A
    Curr Oncol Rep; 2021 Mar; 23(4):44. PubMed ID: 33721122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based integration of selective internal radiation therapy into the management of ocular melanoma liver metastases.
    Stedman B
    Future Oncol; 2014 Nov; 10(15 Suppl):97-100. PubMed ID: 25478778
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablative therapies for liver metastases of gastroenteropancreatic endocrine tumors.
    Ruszniewski P; O'Toole D
    Neuroendocrinology; 2004; 80 Suppl 1():74-8. PubMed ID: 15477722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of neuroendocrine hepatic metastasis.
    Gamblin TC; Christians K; Pappas SG
    Surg Oncol Clin N Am; 2011 Apr; 20(2):273-9, vii-viii. PubMed ID: 21377583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoembolization of hepatic malignancy.
    Gonsalves CF; Brown DB
    Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A long-term survival case of neuroendocrine tumor of the sigmoid colon with multiple liver metastases].
    Yamauchi S; Uetake H; Kikuchi A; Ono H; Matsuyama T; Kato S; Ishiguro M; Ishikawa T; Kobayashi H; Iida S; Higuchi T; Enomoto M; Sugihara K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2271-3. PubMed ID: 22202352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
    Auernhammer CJ; Göke B
    Gut; 2011 Jul; 60(7):1009-21. PubMed ID: 21378384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective internal radiotherapy for advanced liver tumors and metastases].
    Hoffmann RT; Jakobs TF; Tatsch K; Reiser MF
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2099-102. PubMed ID: 18814106
    [No Abstract]   [Full Text] [Related]  

  • 18. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
    Nazario J; Gupta S
    Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interventional therapy of neuroendokrine tumors of the gastrointestinal tract].
    Kettenbach J; Müller SL; Schindl M
    Wien Klin Wochenschr; 2003; 115 Suppl 2():56-64. PubMed ID: 15518148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for management of patients with neuroendocrine liver metastases.
    Frilling A; Modlin IM; Kidd M; Russell C; Breitenstein S; Salem R; Kwekkeboom D; Lau WY; Klersy C; Vilgrain V; Davidson B; Siegler M; Caplin M; Solcia E; Schilsky R;
    Lancet Oncol; 2014 Jan; 15(1):e8-21. PubMed ID: 24384494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.